CD39+CD4+ T cells which upregulate genes associated with an active Treg phenotype (CD25) also predicts poor outcome while high densities of CD39+CD103+CD8+ T cells in the tumor nest which upregulate cytotoxicity—and tissue residency genes, are linked to improved 5-year survival. The gene discussed is CD4; the disease is neoplasm.